Targeting ST8SIA6-AS1 counteracts KRAS<sup>G12C</sup> inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateAll in vivo experiments were carried out according to the institutional ethical guidelines on animal care and were approved by the Institute of Animal Care and Use Committee at the Shanghai Institute of Materia Medica. Consent for publicationAll authors have read the manuscript and provided their consent for the submission. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported by the grants from the Lingang Laboratory (LG202101-01-06) and the Natural Science Foundation of Shanghai (19ZR1467700), and ShanghaiTech University and the Shanghai Municipal Government."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025